150 related articles for article (PubMed ID: 15712603)
1. A novel system to diagnose cutaneous adverse drug reactions employing the cellscan--comparison with histamine releasing test and Inf-gamma Releasing Test.
Goldberg I; Gilburd B; Kravitz MS; Kivity S; Chaim BB; Klein T; Schiffenbauer Y; Trubniykovr E; Brenner S; Shoenfeld Y
Clin Dev Immunol; 2005 Mar; 12(1):85-90. PubMed ID: 15712603
[TBL] [Abstract][Full Text] [Related]
2. Novel interferon-γ enzyme-linked immunoSpot assay using activated cells for identifying hypersensitivity-inducing drug culprits.
Kato K; Kawase A; Azukizawa H; Hanafusa T; Nakagawa Y; Murota H; Sakaguchi S; Asada H; Katayama I
J Dermatol Sci; 2017 Jun; 86(3):222-229. PubMed ID: 28330775
[TBL] [Abstract][Full Text] [Related]
3. Clinical application of static fluorescence-based cytometry, Cellscan, in cutaneous adverse drug reaction.
Salameh F; Kravitz MS; Barzilai A; Baum S; Shoenfeld Y; Schiffenbauer Y; Trubniykov E; Trau H
J Dermatol; 2011 May; 38(5):447-55. PubMed ID: 21352273
[TBL] [Abstract][Full Text] [Related]
4. Sera from patients with multiple drug allergy syndrome contain circulating histamine-releasing factors.
Asero R; Tedeschi A; Lorini M; Caldironi G; Barocci F
Int Arch Allergy Immunol; 2003 Jul; 131(3):195-200. PubMed ID: 12876410
[TBL] [Abstract][Full Text] [Related]
5. Basophil Histamine Release Induced by Amoxicilloyl-poly-L-lysine Compared With Amoxicillin in Patients With IgE-Mediated Allergic Reactions to Amoxicillin.
Arribas F; Falkencrone S; Sola J; Gomez-Serranillos MP; Laguna JJ; Montañez MI; Fernandez TD; Rodríguez D; Pineda F; Skov PS; Mayorga C; Torres MJ
J Investig Allergol Clin Immunol; 2017; 27(6):356-362. PubMed ID: 28628008
[TBL] [Abstract][Full Text] [Related]
6. In vitro release of interferon-gamma from peripheral blood lymphocytes in cutaneous adverse drug reactions.
Goldberg I; Hanson M; Chodick G; Shirazi I; Brenner S
Clin Dev Immunol; 2012; 2012():687532. PubMed ID: 22719779
[TBL] [Abstract][Full Text] [Related]
7. The measurement of drug-induced interferon γ-releasing cells and lymphocyte proliferation in severe cutaneous adverse reactions.
Suthumchai N; Srinoulprasert Y; Thantiworasit P; Rerknimitr P; Tuchinda P; Chularojanamontri L; Rerkpattanapipat T; Chanprapaph K; Disphanurat W; Chakkavittumrong P; Tovanabutra N; Srisuttiyakorn C; Sukasem C; Klaewsongkram J;
J Eur Acad Dermatol Venereol; 2018 Jun; 32(6):992-998. PubMed ID: 29478292
[TBL] [Abstract][Full Text] [Related]
8. Multiple drug allergy in patients with cutaneous adverse drug reactions diagnosed by in vitro drug-induced interferon-gamma release.
Halevy S; Grossman N
Isr Med Assoc J; 2008 Dec; 10(12):865-8. PubMed ID: 19160944
[TBL] [Abstract][Full Text] [Related]
9. In vitro diagnostic assays are effective during the acute phase of delayed-type drug hypersensitivity reactions.
Polak ME; Belgi G; McGuire C; Pickard C; Healy E; Friedmann PS; Ardern-Jones MR
Br J Dermatol; 2013 Mar; 168(3):539-49. PubMed ID: 23106791
[TBL] [Abstract][Full Text] [Related]
10. Interferon-gamma (INF-gamma) release test can detect cutaneous adverse effects to statins.
Goldberg I; Isman G; Shirazi I; Brenner S
Int J Dermatol; 2009 Dec; 48(12):1370-5. PubMed ID: 20415679
[TBL] [Abstract][Full Text] [Related]
11. [Allergic reactions and pseudoallergies in surgical interventions with general anesthesia].
Sánchez Palacios A; Ortiz Ponce M; Rodríguez Pérez A
Allergol Immunopathol (Madr); 2000; 28(1):24-36. PubMed ID: 10757856
[TBL] [Abstract][Full Text] [Related]
12. In vitro rapid diagnostic tests for severe drug hypersensitivity reactions in children.
Haw WY; Polak ME; McGuire C; Erlewyn-Lajeunesse M; Ardern-Jones MR
Ann Allergy Asthma Immunol; 2016 Jul; 117(1):61-6. PubMed ID: 27221062
[TBL] [Abstract][Full Text] [Related]
13. Application of a static fluorescence-based cytometer: the CellScan in clinical immunology.
Szyper-Kravitz M; Harel M; Gilburd B; Trubniykov E; Schiffenbauer YS; Shoenfeld Y
Lupus; 2006; 15(7):436-41. PubMed ID: 16898179
[TBL] [Abstract][Full Text] [Related]
14. Clinical implications of in vitro drug-induced interferon gamma release from peripheral blood lymphocytes in cutaneous adverse drug reactions.
Halevy S; Cohen AD; Grossman N
J Am Acad Dermatol; 2005 Feb; 52(2):254-61. PubMed ID: 15692470
[TBL] [Abstract][Full Text] [Related]
15. Oral challenge in patients with suspected cutaneous adverse drug reactions: findings in 784 patients during a 25-year-period.
Lammintausta K; Kortekangas-Savolainen O
Acta Derm Venereol; 2005; 85(6):491-6. PubMed ID: 16396795
[TBL] [Abstract][Full Text] [Related]
16. [Cutaneous reactions to drugs].
Mulder WM; Meinardi MM; Bruynzeel DP
Ned Tijdschr Geneeskd; 2004 Feb; 148(9):415-20. PubMed ID: 15038200
[TBL] [Abstract][Full Text] [Related]
17. [In vitro interferon-gamma release--a laboratory diagnosis of cutaneous adverse drug reactions].
Halevy S; Cohen AD; Grossman N
Harefuah; 2001 Feb; 140(2):121-4, 190. PubMed ID: 11242915
[TBL] [Abstract][Full Text] [Related]
18. The Combined Utility of Ex Vivo IFN-γ Release Enzyme-Linked ImmunoSpot Assay and In Vivo Skin Testing in Patients with Antibiotic-Associated Severe Cutaneous Adverse Reactions.
Trubiano JA; Strautins K; Redwood AJ; Pavlos R; Konvinse KC; Aung AK; Slavin MA; Thursky KA; Grayson ML; Phillips EJ
J Allergy Clin Immunol Pract; 2018; 6(4):1287-1296.e1. PubMed ID: 29100867
[TBL] [Abstract][Full Text] [Related]
19. Drug-specific in vitro release of IL-2, IL-5, IL-13 and IFN-gamma in patients with delayed-type drug hypersensitivity.
Lochmatter P; Beeler A; Kawabata TT; Gerber BO; Pichler WJ
Allergy; 2009 Sep; 64(9):1269-78. PubMed ID: 19254289
[TBL] [Abstract][Full Text] [Related]
20. [Diagnostic methods for confirming drug-allergy--the lymphocyte transformation test in dermatology].
Makó S; Lepesi-Benko R; Marschalkó M; Soós G; Kárpáti S
Orv Hetil; 2008 Jun; 149(24):1107-14. PubMed ID: 18539577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
